JPRN-UMIN000009695已完成2 期
Multicenter Randomized Phase II Study of consecutive-day versus alternate-day treatment with S-1 as Second-line chemotherapy in advanced pancreatic cancer. - Multicenter Randomized Phase II Study of consecutive-day versus alternate-day treatment with S-1 as Second-line chemotherapy in advanced pancreatic cancer. (SCOTCH)
agoya University Hospital0 个研究点目标入组 200 人开始时间: 2013年1月4日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •The exclusion criteria are as follows active infection.Pregnant or lactating women,women of childbearging age.The patient inappropriate for entry onto this study in the judgment of the investigator.
研究者
相似试验
进行中（未招募）
不适用
Phase II randomized multicenter study of multiple doses of palonosetron plus aprepitant versus multiple doses of palonosetron alone in preventing chemotherapy-induced nausea and vomiting in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome receiving multiple days chemotherapypatients with Acute Myeloid leukemia or high-risk Myelodisplastic syndrome according to IPSS score treated with AML-like multiple days chemotherapy regimenMedDRA version: 14.1Level: SOCClassification code 10005329Term: Blood and lymphatic system disordersSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2011-003823-36-ITASSOCIAZIONE SALENTINA ANGELA SERRA ONLUS
进行中（未招募）
1 期
A multi-center randomized phase II study comparing corticosteroids alone versus corticosteroids and extracorporeal photopheresis as first-line treatment of Grade II acute graft-versus-host disease with skin involvement occuring after allogeneic stem cell transplantation - COPAVEHDIThe study will be proposed to all adult patients receiving an allogeneic hematopopietic stem cell transplantation and presenting a Grade II acute GVH with skin +/- upper gastrointestinal involvement, in transplant centers contributing to this trial (departments of hematology).CTIS2023-508614-41-00CHRU De Nancy78
进行中（未招募）
1 期
Etude comparant l’association corticoïdes et photophérèse extracorporelle au traitement conventionnel par corticoïdes dans le traitement de première ligne de la réaction aiguë du greffon contre l’hôte de grade IIStandard II acute graft-versus-host disease following allogeneic stem cell transplantationEUCTR2017-005162-22-FRCHRU de Nancy78
进行中（未招募）
不适用
Multizentrische randomisierte Phase II Studie zur Therapie des lokal fortgeschrittenen oder metastasierten NSCLC (Stadium IIIB/IV) mit Cisplatin/Docetaxel oder Oxaliplatin/DocetaxelA multicenter randomized phase II trial for the therapy of locally advanced or metastatic NSCLC (stage IIIB/IV) with cisplatin/docetaxel or oxaliplatin/docetaxelEUCTR2008-002197-35-DEKrankenhaus Nordwest GmbH88
进行中（未招募）
1 期
A Study comparing 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) versus Epirubicin, Cisplatin and 5-FU (ECF) in patients with locally advanced resectable gastric cancerEUCTR2010-018754-13-DEKrankenhaus Nordwest GmbH714